Profile data is unavailable for this security.
About the company
Willow Biosciences Inc. is a Canada-based biotechnology company. The Company develops and produces precision fermented functional ingredients for the health and wellness, food and beverage and personal care markets. Its FutureGrown biotechnology platform allows production with sustainability at its core. Its commercial product, Cannabigerol CBG, which is a cannabinoid that has anti-microbial, anti-inflammatory, and antioxidant properties. It also offers BioOxi, a bio-oxidation technology platform. By leveraging BioOxi, commercial partners can revolutionize manufacturing of oxygenated and hydroxylated functional ingredients, such as steroids, polyphenols, oxyterpenes and certain other targeted ingredients produced from such methods. It is also developing BioOxi-based process for production of the generic active pharmaceutical ingredient (API), hydrocortisone, and its derivatives. Its other pipeline products include Ursodeoxycholic acid (UCAC), Astaxanthin, B-carotene and others.
- Revenue in CAD (TTM)949.00k
- Net income in CAD-10.62m
- Incorporated--
- Employees19.00
- LocationWillow Biosciences Inc202, 1201 5th Street SWCALGARY T2R 0Y6CanadaCAN
- Phone+1 (403) 910-5140
- Fax+1 (403) 669-4848
- Websitehttps://www.willowbio.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Khiron Life Sciences Corp | 16.14m | -30.66m | 9.30m | 310.00 | -- | -- | -- | 0.5761 | -0.1674 | -0.1674 | 0.085 | 0.1248 | 0.3078 | 1.33 | 3.90 | 52,055.68 | -58.47 | -- | -69.10 | -- | 19.51 | -- | -190.00 | -- | 0.9133 | -- | 0.0864 | -- | 59.60 | -- | -37.81 | -- | -- | -- |
| Valeo Pharma Inc | 54.86m | -29.77m | 9.87m | 80.00 | -- | -- | -- | 0.1799 | -0.3273 | -0.3273 | 0.6054 | -0.5561 | 1.32 | 4.45 | 9.31 | 438,864.00 | -71.78 | -64.35 | -330.86 | -113.22 | 18.32 | 23.88 | -54.26 | -69.71 | 0.2738 | -1.31 | 5.32 | -- | 94.31 | 65.20 | -8.01 | -- | 76.61 | -- |
| Crescita Therapeutics Inc | 17.92m | -2.34m | 9.92m | 78.00 | -- | 0.5493 | -- | 0.5534 | -0.1162 | -0.1162 | 0.8927 | 0.9285 | 0.6903 | 1.50 | 4.62 | -- | -9.01 | -0.2457 | -11.40 | -0.3059 | 56.03 | 63.41 | -13.06 | -0.3518 | 2.60 | -- | 0.0594 | -- | -25.52 | 1.05 | -330.39 | -- | -1.58 | -- |
| Willow Biosciences Inc | 949.00k | -10.62m | 14.64m | 19.00 | -- | 9.46 | -- | 15.43 | -0.0853 | -0.0853 | 0.0076 | 0.0122 | 0.105 | -- | 3.16 | 49,947.37 | -117.47 | -- | -144.53 | -- | -- | -- | -1,118.76 | -- | 1.29 | -- | 0.5682 | -- | 42.75 | -- | 12.05 | -- | -- | -- |
| Avricore Health Inc | 3.98m | -341.17k | 16.48m | -- | -- | 7.42 | 149.46 | 4.14 | -0.0034 | -0.0034 | 0.0399 | 0.0222 | 1.56 | -- | 11.91 | -- | -13.39 | -85.75 | -16.61 | -142.65 | 37.12 | 31.65 | -8.57 | -116.09 | 1.82 | -67.22 | 0.00 | -- | 97.08 | 196.15 | 14.30 | -- | 80.26 | -- |
| Cytophage Technologies Ltd | 0.00 | -7.76m | 19.62m | -- | -- | 3.02 | -- | -- | -0.6074 | -0.6074 | 0.00 | 0.121 | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -463.03 | 0.2085 | -- | -- | -- | -25.88 | -- | -- | -- |
